1. Mazzitelli M, Sasset L, Mengato D, Cattelan A, et al.
   I would but I cannot, I can but I do not want: unmet needs of people with HIV in the long-acting era.
   AIDS 2023;37:707-708.
   


2. Teng AE, Hsue PY, Secemsky EA.
   Response to correspondence to "Temporal trends and outcomes of peripheral artery disease revascularization and amputation among the HIV population".
   AIDS 2023;37:706.
   


3. Britton MK.
   Response to "Temporal trends and outcomes of peripheral artery disease revascularization and amputation among the HIV population".
   AIDS 2023;37:705.
   


4. Heath SL, Bansal A.
   Mpox infection in people living with HIV.
   AIDS 2023;37:701-703.
   


5. Gener A.
   Sparse data obscure an unchecked Russian HIV epidemic.
   AIDS 2023;37:697-699.
   


6. Laurence J, Winslow DL.
   Distinct inflammatory profiles linked to cardiovascular disease risk in HIV infection: implications for the design of preventive and therapeutic interventions.
   AIDS 2023;37:693-695.
   


7. Wood BR, Kassaye SG, Gerstoft J.
   Long-acting cabotegravir/rilpivirine for HIV-1 treatment: real-world evaluation of barriers to implementation.
   AIDS 2023;37:689-691.
   


8. Aravantinou M, Plagianos M, Kokogho A, Adebajo S, et al.
   HSV-2 prevalence and association with inflammatory cytokines among sexual and gender minorities (SGM) living with and without HIV-1 from Lagos, Nigeria.
   AIDS Res Hum Retroviruses 2023.
   


9. Rachel G, Vembuli H, Kumar C P G, Hanna LE, et al.
   Immune cell cross talk in the establishment of HIV-1 latency.
   AIDS Res Hum Retroviruses 2023.
   


10. De Schacht C, Amorim G, Van Rompaey S, Melo M, et al.
    Favorable Impact of Community Adherence Support Groups on Retention in Care and Viral Suppression Rates among Persons with HIV Receiving Antiretroviral Therapy in Mozambique.
    AIDS Res Hum Retroviruses 2023.
    


11. Murenzi G, Kim HY, Shi Q, Muhoza B, et al.
    Association between Time to Antiretroviral Therapy and Loss to Care Among Newly Diagnosed Rwandan People Living with Human Immunodeficiency Virus.
    AIDS Res Hum Retroviruses 2023.
    


12. Person AK, Ramirez BC, Kim A, Veloso V, et al.
    Cryptococcal Meningitis and Clinical Outcomes in Persons with HIV: A Global View.
    Clin Infect Dis 2023.
    


13. Nosyk B, Fojo AT, Kasaie P, Enns B, et al.
    The testing imperative: Why the US EHE needs to renew efforts to expand HIV testing in clinical and community-based settings.
    Clin Infect Dis 2023.
    


14. O'Shea J, Fanfair RN, Williams T, Khalil G, et al.
    The Cooperative Re-Engagement Controlled Trial (CoRECT): Durable Viral Suppression Assessment.
    J Acquir Immune Defic Syndr 2023.
    


15. Bollinger JM, Geller G, May E, Brewer J, et al.
    Challenges in Obtaining the Informed Perspectives of Stakeholders regarding HIV Molecular Epidemiology.
    J Acquir Immune Defic Syndr 2023.
    


16. Elbur AI, Ghebremichael M, Konkle-Parker D, Jones DL, et al.
    Trajectories of Antiretroviral Therapy Adherence and Virologic Failure in Women with HIV in the United States.
    J Acquir Immune Defic Syndr 2023.
    


17. Di PR, Van Leeuwen MT, Amin J, Vajdic CM, et al.
    Second primary cancers in people with HIV/AIDS: a national data linkage study of incidence and risk factors.
    J Acquir Immune Defic Syndr 2023.
    


18. Arango-Franco CA, Migaud M, Ramirez-Sanchez IC, Arango-Bustamante K, et al.
    Anti-GM-CSF Neutralizing Autoantibodies in Colombian Patients with Disseminated Cryptococcosis.
    J Clin Immunol 2023.
    


19. Li Y, You S, Lee K, Yaesoubi R, et al.
    The estimated lifetime quality-adjusted life-years lost due to chlamydia, gonorrhea, and trichomoniasis in the United States in 2018.
    J Infect Dis 2023.
    


20. Harfouche M, Alareeki A, Osman AMM, Alaama AS, et al.
    Epidemiology of herpes simplex virus type 2 in the Middle East and North Africa: Systematic review, meta-analyses, and meta-regressions.
    J Med Virol 2023.
    


21. Nguyen HT, Wang Q, Anang S, Sodroski JG, et al.
    Characterization of the Human Immunodeficiency Virus (HIV-1) Envelope Glycoprotein Conformational States on Infectious Virus Particles.
    J Virol 2023.
    


22. Jensen BO, Knops E, Cords L, Lubke N, et al.
    In-depth virological and immunological characterization of HIV-1 cure after CCR5Delta32/Delta32 allogeneic hematopoietic stem cell transplantation.
    Nat Med 2023.
    


23. Paton NI, Cousins C, Suresh C, Burhan E, et al.
    Treatment Strategy for Rifampin-Susceptible Tuberculosis.
    N Engl J Med 2023.
    


24. Kupferschmid K.
    Deadly mpox risk in people with untreated HIV comes into view.
    Science 2023;379:745.
    


25. Mahase E.
    Mpox: Clinicians identify severe form with high mortality in advanced HIV patients.
    BMJ 2023;380:p422.
    

Display articles in

• Abstract format
• Medline format